UK

After protests, pharma industry reaches 'landmark' drug spending deal with UK government
After protests, pharma industry reaches 'landmark' drug spending deal with UK government
Fierce Pharma
UK
drug pricing
NHS
Flag link:
What to know about the U.K.’s approval of the first CRISPR treatment for diseases
What to know about the U.K.’s approval of the first CRISPR treatment for diseases
Nature
UK
CRISPR
gene editing
Casgevy
Vertex Pharmaceuticals
CRISPR Therapeutics
Flag link:
Vertex, CRISPR Win World’s First Approval for CRISPR-Edited Therapy from UK
Vertex, CRISPR Win World’s First Approval for CRISPR-Edited Therapy from UK
BioSpace
CRISPR
gene editing
Vertex Pharmaceuticals
CRISPR Therapeutics
UK
Casgevy
beta thalassemia
Flag link:
Lilly, AbbVie, BMS and more rally against UK's 'arbitrary' growth cap on branded drug market
Lilly, AbbVie, BMS and more rally against UK's 'arbitrary' growth cap on branded drug market
Fierce Pharma
UK
drug pricing
ABPI
Flag link:
Cat allergy vaccine trial gets go-ahead to launch in UK
Cat allergy vaccine trial gets go-ahead to launch in UK
Clinical Trials Arena
Angany
cat allergy
vaccines
allergy vaccines
UK
ANG-101
Flag link:
Abbott’s Biowearable Performs Well In U.K. Ahead Of U.S. Launch
Abbott’s Biowearable Performs Well In U.K. Ahead Of U.S. Launch
Forbes
Abbott Labs
biowearables
UK
diabetes
Lingo
devices
Medtech
Flag link:
Eli Lilly receives UK approval for ulcerative colitis treatment
Eli Lilly receives UK approval for ulcerative colitis treatment
Biopharma Reporter
Eli Lilly
NICE
UK
ulcerative colitis
mirikizumab
Flag link:
Novartis hit with another serious drug marketing breach, this time for multiple sclerosis therapy Mayzent
Novartis hit with another serious drug marketing breach, this time for multiple sclerosis therapy Mayzent
Fierce Pharma
Novartis
UK
PMCPA
pharma marketing
Mayzent
Flag link:
AlveoGene debuts to develop inhaled gene therapy technology
AlveoGene debuts to develop inhaled gene therapy technology
Pharmaphorum
Alvogene
UK
startups
lentiviral vectors
gene therapy
drug delivery
Flag link:
NICE changes its mind on Lilly's Mounjaro for diabetes
NICE changes its mind on Lilly's Mounjaro for diabetes
Pharmaphorum
Eli Lilly
Mounjaro
diabetes
NHS
UK
Flag link:
Novo Nordisk launches Wegovy for obese patients in UK
Novo Nordisk launches Wegovy for obese patients in UK
Pharmaceutical Business Review
Novo Nordisk
UK
Wegovy
obesity
Flag link:
The BMJ's editor-in-chief wants action on pharma payments to leading doctor education groups in the UK
The BMJ's editor-in-chief wants action on pharma payments to leading doctor education groups in the UK
Fierce Pharma
BMJ
UK
pharma industry
physicians
physician payments
Flag link:
Haleon plots massive layoffs in UK and beyond to save cost: report
Haleon plots massive layoffs in UK and beyond to save cost: report
Fierce Pharma
GSK
Haleon
consumer healthcare
layoffs
UK
Flag link:
FourPlus to create mixed-reality training platform for biopharma and healthcare sectors
FourPlus to create mixed-reality training platform for biopharma and healthcare sectors
Biopharma Reporter
FourPlus
mixed reality
training
UK
Flag link:
BMS’ Sotyktu cleared for NHS use in psoriasis
BMS’ Sotyktu cleared for NHS use in psoriasis
Pharmaphorum
Bristol Myers Squibb
Sotyktu
psoriasis
NHS
UK
Flag link:
AstraZeneca, Merck's Lynparza picks up new NICE recommendation
AstraZeneca, Merck's Lynparza picks up new NICE recommendation
Fierce Pharma
AstraZeneca
Merck
Lynparza
NICE
UK
ovarian cancer
fallopian tube cancer
Flag link:
GSK faces strike threat in UK, again, after workers pan pay raise
GSK faces strike threat in UK, again, after workers pan pay raise
Fierce Pharma
GSK
UK
strike
Flag link:
GSK told to pay higher royalties to AZ on Zejula sales
GSK told to pay higher royalties to AZ on Zejula sales
Pharmaphorum
GSK
AstraZeneca
ovarian cancer
Zejula
legal
UK
Flag link:
AstraZeneca, Amgen's asthma launch Tezspire picks up backing from England's NICE
AstraZeneca, Amgen's asthma launch Tezspire picks up backing from England's NICE
Fierce Pharma
AstraZeneca
Amgen
Tezspire
UK
NICE
asthma
severe asthma
Flag link:
‘Huge boost for biotech companies’: UK life sciences industry welcomes new enhanced R&D tax relief rate
‘Huge boost for biotech companies’: UK life sciences industry welcomes new enhanced R&D tax relief rate
Biopharma Reporter
biotech
UK
innovation
R&D
Flag link:

Pages